AU2005299341A1 - Method to promote wound healing - Google Patents
Method to promote wound healing Download PDFInfo
- Publication number
- AU2005299341A1 AU2005299341A1 AU2005299341A AU2005299341A AU2005299341A1 AU 2005299341 A1 AU2005299341 A1 AU 2005299341A1 AU 2005299341 A AU2005299341 A AU 2005299341A AU 2005299341 A AU2005299341 A AU 2005299341A AU 2005299341 A1 AU2005299341 A1 AU 2005299341A1
- Authority
- AU
- Australia
- Prior art keywords
- substance
- wound
- mammal
- administered
- met
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/046—Tachykinins, e.g. eledoisins, substance P; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US62201504P | 2004-10-27 | 2004-10-27 | |
| US60/622,015 | 2004-10-27 | ||
| PCT/US2005/038646 WO2006047625A2 (en) | 2004-10-27 | 2005-10-25 | Method to promote wound healing |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2005299341A1 true AU2005299341A1 (en) | 2006-05-04 |
Family
ID=36228442
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2005299341A Abandoned AU2005299341A1 (en) | 2004-10-27 | 2005-10-25 | Method to promote wound healing |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20080318869A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1809313A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2008518020A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2005299341A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2585265A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2006047625A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101621149B1 (ko) | 2014-07-09 | 2016-05-16 | 계명대학교 산학협력단 | 만성 창상용 동물 모델 |
| US9474894B2 (en) | 2014-08-27 | 2016-10-25 | Aleva Neurotherapeutics | Deep brain stimulation lead |
| KR101825041B1 (ko) * | 2016-04-07 | 2018-02-02 | 주식회사 바이오솔루션 | 물질 p를 포함하는 상처치유용 약학 조성물 |
| WO2018014016A1 (en) * | 2016-07-15 | 2018-01-18 | New Amsterdam Sciences | Substance and method for treating radiation exposure |
| JP6901801B2 (ja) * | 2017-06-14 | 2021-07-14 | バイオソリューション カンパニー・リミテッドBio Solution Co Ltd | 物質pを含むしわの改善または抗炎症化粧料組成物 |
| KR102158969B1 (ko) * | 2018-10-19 | 2020-09-23 | 주식회사 바이오솔루션 | 물질 p를 포함하는 난치성 궤양 치료용 조성물 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5616562A (en) * | 1990-04-27 | 1997-04-01 | Murphy; Christopher J. | Methods and compositions using substance P to promote wound healing |
| US5945508A (en) * | 1996-07-23 | 1999-08-31 | Witten; Mark L. | Substance P treatment for immunostimulation |
| JP4096115B2 (ja) * | 2000-08-10 | 2008-06-04 | 輝夫 西田 | 皮膚創傷治癒促進剤 |
| AU7776701A (en) * | 2000-08-10 | 2002-02-25 | Santen Pharmaceutical Co Ltd | Skin wound healing promoters |
| US20060153789A1 (en) * | 2002-12-18 | 2006-07-13 | Witten Mark L | Stimulation of hair regrowth |
| US20070154448A1 (en) * | 2005-11-22 | 2007-07-05 | Ted Reid | Methods and compositions using Substance P to promote wound healing |
-
2005
- 2005-10-25 AU AU2005299341A patent/AU2005299341A1/en not_active Abandoned
- 2005-10-25 CA CA002585265A patent/CA2585265A1/en not_active Abandoned
- 2005-10-25 EP EP05813067A patent/EP1809313A4/en not_active Withdrawn
- 2005-10-25 US US11/666,474 patent/US20080318869A1/en not_active Abandoned
- 2005-10-25 WO PCT/US2005/038646 patent/WO2006047625A2/en not_active Ceased
- 2005-10-25 JP JP2007539081A patent/JP2008518020A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP1809313A4 (en) | 2008-01-23 |
| WO2006047625A2 (en) | 2006-05-04 |
| WO2006047625A3 (en) | 2006-07-27 |
| EP1809313A2 (en) | 2007-07-25 |
| CA2585265A1 (en) | 2006-05-04 |
| US20080318869A1 (en) | 2008-12-25 |
| JP2008518020A (ja) | 2008-05-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2255737C2 (ru) | Анальгезирующие композиции, содержащие бупренорфин | |
| Straube et al. | Studies with cysteinamine and cysteine in x-irradiated animals | |
| US20080318869A1 (en) | Method to Promote Wound Healing | |
| JP5823486B2 (ja) | 放射線および熱の複合損傷の治療方法 | |
| Reyes-Vazquez et al. | Alpha-interferon suppresses food intake and neuronal activity of the lateral hypothalamus | |
| Hope et al. | Release of immunoreactive galanin in the spinal cord of rats with ankle inflammation: studies with antibody microprobes | |
| JP6150374B2 (ja) | 放射線被ばく治療剤及び放射線被ばく治療方法 | |
| US20230270739A1 (en) | Methods and Compositions for Treating Pain While Minimizing the Risk of Opioid Addiction | |
| Mazarati et al. | Felbamate in experimental model of status epilepticus | |
| JPH07165582A (ja) | 免疫抗癌剤の抗癌効果増強剤 | |
| Renecker et al. | Antagonism of xylazine hydrochloride with yohimbine hydrochloride and 4-aminopyridine in captive wapiti | |
| AU2445900A (en) | Regulation of anaesthesia | |
| RU2232501C2 (ru) | Способ повышения естественной резистентности животных | |
| JP2008518020A5 (cg-RX-API-DMAC7.html) | ||
| KR20050086819A (ko) | 알파 티모신을 사용한 방사능 손상에 대한 보호방법 | |
| EP4506012A1 (en) | Use of extracts from rabbit skin inflamed by vaccinia virus in treatment of alzheimer's disease | |
| US20240415937A1 (en) | Theophylline-loaded collagen nanoparticles | |
| Reuter et al. | Current capture technique and drug dosage regime for the immobilization and tranquilization of free-ranging black rhinoceros (Diceros bicornis bicornis) in Namibia | |
| CN121846176A (zh) | 一种止痛穴位贴膏及其制备方法 | |
| JP2001057828A (ja) | 癌性疼痛モデル動物及びそれを用いた癌性疼痛の強さの評価方法 | |
| Sloan et al. | Diazepam-treated female rats: flumazenil-and PK 11195-induced withdrawal in the hippocampus CA1 | |
| RU2018310C1 (ru) | Средство для лечения длительно незаживающих ран и трофических язв | |
| RU2061492C1 (ru) | Противовоспалительное средство для лечения ретикулоперитонитов крупного рогатого скота | |
| WO2015195894A1 (en) | Methods and compositions for the modulation of beta-endorphin levels | |
| Khorunzhii et al. | Temporal patterns of spontaneous activity of auditory cortex neurons in lightly anesthetized and awake mice |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK5 | Application lapsed section 142(2)(e) - patent request and compl. specification not accepted |